Health In Tech, Inc. (HIT) Form S-3/A — Oct 9, 2026
Health In Tech filed an S-3/A registering up to 34,224,247 Class A shares for resale by Yorkville under the $20.0 million Standby Equity Purchase Agreement dated August 12, 2026, comprising up to 9,532,889 conversion shares from convertible notes and up to 24,691,358 advance shares. If fully issued, the registered shares would represent approximately 39.0% of the 53,600,790 shares outstanding and about 62.3% of the non-affiliate float as of October 6, 2026, creating a major dilution overhang for the micro-cap stock trading at $0.81.
Key figures
- Debt Amount
- 15000000
- Interest Rate
- 8.75
- Maturity Date
- February 18, 2028
- Gross Proceeds
- 35000000
- Offering Price
- 0.81
- Shares Offered
- 34224247
- Shares Outstanding
- 53600790
- Vwap discount
- 97% of lowest daily VWAP over 3-day pricing period
- Advance shares
- 24691358
- Payment premium
- 4%
- Sepa commitment
- $20.0 million
- Conversion shares
- 9532889
- Second tranche net
- 2850000
- Exchange cap shares
- 13100378
- First note principal
- 7000000
- Default interest rate
- 18
- Second note principal
- 3000000
- Fixed conversion price
- 1.5735
- Dilution pct of outstanding
- 39.0%
- Prepaid advance first tranche net
- 6650000
- Dilution pct of non affiliate float
- 62.3%
AI analysis
Red flags7 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.